Harold Punnett

This profile gathers the share dealings of Harold Punnett in NervGen Pharma Corp. We count 13 filings; the first trade dates from 19 January 2017 and the latest from 4 September 2026.

Purchases make up the whole of the open-market record (2 purchases, €124k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 6 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

The newest entry dates from 9 September 2026: an option exercise of €79k, in NervGen Pharma Corp. The last purchase on record was published on 4 May 2026, which is 176 days ago. The median gap between a trade and its publication by SEDI is 5 days. This delay matters because a trade only becomes useful information once it is public. This summary is built from SEDI disclosures alone and does not predict where the share price will go.